By: James Gallagher From: bbc.com Bacteria living deep inside the digestive system seem to alter how cancer drugs work, a study suggests. Immunotherapies – which harness the body’s own defences to fight tumours – can clear even terminal cancer in a small proportion of patients. However, a small study by the University of Texas found those harbouring a more diverse …
Weight loss condition provides clues to why cancer immunotherapy may fail in many patients
Source: University of Cambridge From: news-medical.net A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy – a new approach to treating cancer by boosting a patient’s immune system — may fail in a substantial number of patients. Cancer immunotherapies involve activating a patient’s immune cells to recognise and destroy cancer cells. They …
New safer gene therapy may reduce cancer risk: study
By: PTI From: indianexpress.com Scientists have developed a new safer gene therapy that may reduce the risk of cancer and can be used for many blood diseases. Researchers at Washington State University in the US identified a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy. They altered the way a …
Device Lets Cancer Patients Assist in Their Own Breast Reconstruction, at Home
By: Emily Mullin From: technologyreview.com/ A needleless, remote-controlled device for tissue expansion is awaiting FDA approval. After being diagnosed with breast cancer in December 2015, Cindy Shanker, 67, of Los Gatos, California, got a double mastectomy on the advice of her oncologist. A few months later, her surgeon asked if she wanted to join a clinical trial for an experimental …
Prevent Cancer Foundation Releases New Tool Showing Inconsistent Insurance Policies for Cancer Screening
Cancer screening is one of the country’s greatest public health achievements, yet insurance coverage of screening for five different types of cancer varies by health care plan, according to a new review by the Prevent Cancer Foundation. Along with the review, the Foundation released a new digital tool that allows anyone to easily compare their plan’s coverage of screening tests …
Researchers identify marker of aggressive disease for papillary thyroid cancer
Source: University of Alberta Faculty of Medicine & Dentistry From: news-medical.net A new discovery from University of Alberta scientists represents an important milestone in the fight against thyroid cancer. In a study published in EBioMedicine and recently presented at the American Thyroid Association annual meeting, the team has identified a marker of aggressive disease for papillary thyroid cancer, which comprises …
Palliative care should be standard in cancer treatment: guideline
Source: Reuters From: foxnews.com For patients with advanced cancer, palliative care should start early and be an integral part of treatment, not just something added on near the end of life, according to a new practice guideline from the American Society for Clinical Oncology (ASCO). Expanding on a 2012 opinion, the guideline authors say that caregivers of advanced-cancer patients and …
Silencing SIRT2, a sirtuin enzyme, reduces malignancy in deadly breast cancer subtype
Source: Tuft University From: sciencedaily.com Silencing SIRT2, a member of the sirtuin family of enzymes, reduces the invasiveness of basal-like breast cancer cells in culture and inhibits tumor growth in mice, according to new research led by scientists from Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts in Boston. The absence of SIRT2 …
Two New Studies Document Improvement in Breast Cancer Treatment with Use of BioZorb Implant
Studies Report Three-Dimensional Marker Aids Surgeons, Radiation Oncologists and Radiologists Two new studies have documented the value of the BioZorb® marker in improving the treatment of women who have breast cancer. The first study, a peer-reviewed article appearing in the World Journal of Surgery, outlines how the three-dimensional, bioabsorbable marker provides more accurate targeting of the cancer tumor bed for …
Decade-old cancer research grant paying dividends
By: Bonita Cornute From: fox2now.com The American Cancer Society is investing $74 million in breast cancer research. A grant awarded 10 years to Washington University Medical School has resulted in exciting discoveries. The fight against an invasive breast cancer has strong local ties. From lab work to clinical trials, local research creates a strategy for effective diagnosis and treatment. In …